A detailed history of Lake Street Advisors Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lake Street Advisors Group, LLC holds 2,616 shares of VRTX stock, worth $1.22 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,616
Previous 5,297 50.61%
Holding current value
$1.22 Million
Previous $2.48 Million 51.01%
% of portfolio
0.06%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$460.0 - $505.78 $1.23 Million - $1.36 Million
-2,681 Reduced 50.61%
2,616 $1.22 Million
Q2 2024

Aug 05, 2024

BUY
$392.81 - $485.53 $29,853 - $36,900
76 Added 1.46%
5,297 $2.48 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $1.56 Million - $1.71 Million
3,835 Added 276.7%
5,221 $2.18 Million
Q4 2023

May 30, 2024

SELL
$343.0 - $410.68 $90,209 - $108,008
-263 Reduced 5.04%
4,958 $2.02 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $475,398 - $569,202
1,386 New
1,386 $563,000
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $195,927 - $231,049
-1,045 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $4,761 - $5,550
23 Added 2.25%
1,045 $225,000
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $20,701 - $27,608
-100 Reduced 8.91%
1,022 $242,000
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $16,872 - $20,004
66 Added 6.25%
1,122 $305,000
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $33,596 - $44,074
149 Added 16.43%
1,056 $307,000
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $181,191 - $224,763
907 New
907 $216,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lake Street Advisors Group, LLC Portfolio

Follow Lake Street Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lake Street Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lake Street Advisors Group, LLC with notifications on news.